Shares of AmerisourceBergen Corp. (NYSE:ABC) have been given a consensus rating of “Hold” by the nineteen ratings firms that are presently covering the company. Ten equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $95.32.

Several research analysts have recently commented on the company. Leerink Swann reiterated a “buy” rating on shares of AmerisourceBergen Corp. in a report on Wednesday, August 3rd. Deutsche Bank AG lifted their price objective on AmerisourceBergen Corp. from $83.00 to $96.00 and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Barclays PLC lifted their price objective on AmerisourceBergen Corp. from $83.00 to $89.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 3rd. Citigroup Inc. lifted their price objective on AmerisourceBergen Corp. from $100.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, August 3rd. Finally, FBR & Co lifted their price objective on AmerisourceBergen Corp. from $84.00 to $90.00 and gave the stock a “mkt perform” rating in a report on Wednesday, August 3rd.

In other news, insider Gina Clark sold 2,247 shares of the business’s stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $89.50, for a total value of $201,106.50. Following the sale, the insider now directly owns 9,436 shares of the company’s stock, valued at approximately $844,522. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Henry Wadsworth Mcgee III sold 3,351 shares of the business’s stock in a transaction that occurred on Wednesday, September 21st. The stock was sold at an average price of $82.10, for a total value of $275,117.10. Following the completion of the sale, the director now directly owns 10,901 shares in the company, valued at $894,972.10. The disclosure for this sale can be found here. 6.90% of the stock is owned by insiders.

Hedge funds have recently modified their holdings of the company. Fiduciary Management Inc. WI boosted its stake in shares of AmerisourceBergen Corp. by 48.1% in the second quarter. Fiduciary Management Inc. WI now owns 3,987,920 shares of the company’s stock worth $316,322,000 after buying an additional 1,294,938 shares in the last quarter. Burgundy Asset Management Ltd. raised its position in shares of AmerisourceBergen Corp. by 17.9% in the second quarter. Burgundy Asset Management Ltd. now owns 2,614,053 shares of the company’s stock worth $207,347,000 after buying an additional 396,778 shares during the last quarter. Artisan Partners Limited Partnership purchased a new position in shares of AmerisourceBergen Corp. during the second quarter worth $112,709,000. Acadian Asset Management LLC raised its position in shares of AmerisourceBergen Corp. by 21.6% in the second quarter. Acadian Asset Management LLC now owns 1,341,181 shares of the company’s stock worth $106,383,000 after buying an additional 238,198 shares during the last quarter. Finally, Royal Bank of Canada raised its position in shares of AmerisourceBergen Corp. by 6.8% in the second quarter. Royal Bank of Canada now owns 1,283,381 shares of the company’s stock worth $101,799,000 after buying an additional 82,034 shares during the last quarter. 66.19% of the stock is currently owned by hedge funds and other institutional investors.

AmerisourceBergen Corp. (NYSE:ABC) traded up 1.099% on Wednesday, reaching $80.485. The company had a trading volume of 1,182,335 shares. The firm has a market capitalization of $17.28 billion, a price-to-earnings ratio of 10.857 and a beta of 0.74. The company’s 50 day moving average is $84.02 and its 200-day moving average is $82.91. AmerisourceBergen Corp. has a one year low of $73.31 and a one year high of $105.81.

AmerisourceBergen Corp. (NYSE:ABC) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.37 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.10. The firm had revenue of $36.90 billion for the quarter, compared to the consensus estimate of $36.57 billion. AmerisourceBergen Corp. had a return on equity of 83.93% and a net margin of 1.14%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.20 earnings per share. On average, equities research analysts expect that AmerisourceBergen Corp. will post $5.55 earnings per share for the current fiscal year.

About AmerisourceBergen Corp.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers.

5 Day Chart for NYSE:ABC

Receive News & Stock Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related stocks with our FREE daily email newsletter.